Ceramide galactosyltransferase (UGT8) is a molecular marker of breast cancer malignancy and lung metastases
Open Access
- 20 July 2010
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 103 (4), 524-531
- https://doi.org/10.1038/sj.bjc.6605750
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 52 references indexed in Scilit:
- Lung metastasis genes couple breast tumor size and metastatic spreadProceedings of the National Academy of Sciences, 2007
- A house divided: Ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell deathBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- A molecular signature of metastasis in primary solid tumorsNature Genetics, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Cloning, Characterization, and Expression of Human Ceramide Galactosyltransferase cDNABiochemical and Biophysical Research Communications, 1997
- Metabolic and functional aspects of sulfogalactolipidsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Gangliosides and neutral glycolipids of human adrenal medullaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Galactosylceramide is the major cerebroside of human milk fat globule membraneBiochemical and Biophysical Research Communications, 1979